{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T09:47:09Z","timestamp":1791798429428,"version":"4.3.4"},"reference-count":4,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Bei Jing Life Oasis Public Service Center","award":["HT20241219-10922"],"award-info":[{"award-number":["HT20241219-10922"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,6]]},"DOI":"10.1093\/jac\/dkag345","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:22:37Z","timestamp":1790594557000},"source":"Crossref","is-referenced-by-count":0,"title":["Direct measurement of eravacycline effluent concentrations during continuous venovenous haemodiafiltration: negligible clearance in a critically ill patient"],"prefix":"10.1093","volume":"81","author":[{"given":"Guanghui","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, The Central Hospital of Xiangtan (the Affiliated Hospital of Hunan University) , Xiangtan ,","place":["China"]},{"name":"Department of Pharmacy, The Second Xiangya Hospital, Central South University , Changsha ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Xiangya Hospital, Central South University , Changsha ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University , Changsha ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongshan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University , Changsha ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-2450","authenticated-orcid":false,"given":"Jian","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Second Xiangya Hospital, Central South University , Changsha ,","place":["China"]},{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University , Changsha ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"2026101205045641500_dkag345-B1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of eravacycline, a novel fluorocycline antibacterial agent","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"2026101205045641500_dkag345-B2","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1128\/AAC.00240-16","article-title":"Eravacycline pharmacokinetics and challenges in defining humanized exposure in vivo","volume":"60","author":"Thabit","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026101205045641500_dkag345-B3","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1093\/jac\/dkab238","article-title":"Eravacycline pharmacokinetics in a critically ill patient receiving venovenous extracorporeal membrane oxygenation and continuous venovenous haemodialysis","volume":"76","author":"Igneri","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2026101205045641500_dkag345-B4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkag178","article-title":"Population pharmacokinetic analysis and dosing regimen optimization of eravacycline in critically ill patients with carbapenem-resistant Acinetobacter baumannii pneumonia","volume":"81","author":"Lou","year":"2026","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/11\/dkag345\/71859806\/dkag345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/11\/dkag345\/71859806\/dkag345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T09:05:01Z","timestamp":1791795901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag345\/8909082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":4,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag345","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,10,6]]},"article-number":"dkag345"}}